America Latina Times
SEE OTHER BRANDS

The most trusted news from Latin America

America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on August 7, 2025

Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update

Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update

– Registrational cohort enrollment in RESET-Myositis™ trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis – – Five disease-specific cohorts fully enrolled in the RESET™ clinical development program from over 70 …

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …

Verano Announces Resignation of Company President Darren Weiss

Verano Announces Resignation of Company President Darren Weiss

CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the resignation of Darren Weiss from his role as Company President to …

ProQR Announces Second Quarter 2025 Operating and Financial Results

ProQR Announces Second Quarter 2025 Operating and Financial Results

Submitted CTA for lead program AX-0810, targeting NTCP for cholestatic diseases Advancing AX-2402 program toward clinical candidate selection, targeting MECP2 (R270X) for Rett Syndrome Hosting fall Analyst and Investor Event (virtual), featuring detailed …

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance

Second quarter performance driven by strong portfolio royalty revenue growth of 57% 2025 full year revenue guidance increased to $200 million - $225 million (previously $180 million - $200 million) and adjusted earnings per diluted share1 increased to $6. …

NexGold Intersects 23.73 g/t Gold over 5.3 Metres and 24.65 g/t Gold over 2.2 Metres at the Goldboro Open Pit Gold Project

NexGold Intersects 23.73 g/t Gold over 5.3 Metres and 24.65 g/t Gold over 2.2 Metres at the Goldboro Open Pit Gold Project

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …

Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update

Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update

RAP-219 Phase 2a trial in patients with drug-resistant focal onset seizures is fully enrolled and on track for topline results in September 2025 Phase 2 trial of RAP-219 in bipolar mania has been initiated and is enrolling patients; trial remains on track, …

Aya Gold & Silver Receives US$8 Million in Compensation Related to Zgounder Expansion

Aya Gold & Silver Receives US$8 Million in Compensation Related to Zgounder Expansion

MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) announces that its subsidiary, Zgounder Millenium Silver Mining (“ZMSM”), has received a payment of approximately US$8 million under …

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update

‒ Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm ‒ ‒ Company Announces Acquisition of Melinta Therapeutics ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., Aug. 07, 2025 (GLOBE …

Tecnoglass Reports Record Second Quarter 2025 Results

Tecnoglass Reports Record Second Quarter 2025 Results

- Record Quarterly Revenue of $255.5 Million, Up 16.3% Year-Over-Year with Double Digit Organic Growth in Both Single-Family Residential and Multi-Family/Commercial Businesses - - Single-Family Residential Revenue Achieved a Second Quarter Record of $109.6 …

Surge Copper Announces Commencement of 2025 Field Program at Berg Project

Surge Copper Announces Commencement of 2025 Field Program at Berg Project

Vancouver, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to provide an update on its 2025 field program, which commenced in mid-July at the Company …

HUTCHMED Reports 2025 Interim Results

HUTCHMED Reports 2025 Interim Results

— Indications expansion driving growth and ATTC platform enriching pipeline — — $455 million in net income attributable to HUTCHMED driven by non-core partial disposal — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- …

XORTX Provides Corporate Update and Planned Activities for 2025 / 2026

XORTX Provides Corporate Update and Planned Activities for 2025 / 2026

CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings

Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential Transaction expected to be near-term …

Verano Announces Second Quarter 2025 Financial Results

Verano Announces Second Quarter 2025 Financial Results

CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the second quarter ended June 30, 2025, which …

Brookfield Wealth Solutions Announces Second Quarter Results and Three-for-Two Stock Split

Brookfield Wealth Solutions Announces Second Quarter Results and Three-for-Two Stock Split

BROOKFIELD, NEWS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Brookfield Wealth Solutions (NYSE, TSX: BNT) today announced financial results for the quarter ended June 30, 2025. Sachin Shah, CEO of Brookfield Wealth Solutions, stated, “Our business continues to …

Zapp EV Secures Uplisting to OTCQB Venture Market

Zapp EV Secures Uplisting to OTCQB Venture Market

LONDON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Zapp Electric Vehicles Group Limited (OTCQB: ZAPPF) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to electrify personal urban mobility, today announced its ordinary …

Accumulus Synergy gliedert Accumulus Technologies aus, um bewährte Regulierungsplattform zu skalieren und den globalen Zugang zu Therapien zu beschleunigen

Accumulus Synergy gliedert Accumulus Technologies aus, um bewährte Regulierungsplattform zu skalieren und den globalen Zugang zu Therapien zu beschleunigen

BURLINGAME, Kalifornien, Aug. 07, 2025 (GLOBE NEWSWIRE) -- In einem richtungsweisenden Schritt zur Förderung regulatorischer Innovationen und zur besseren Deckung der weltweit steigenden Nachfrage hat Accumulus Synergy, ein gemeinnütziger Branchenverband, …

Accumulus Synergy crée Accumulus Technologies pour développer sa plateforme réglementaire éprouvée et accélérer l’accès mondial aux thérapies

Accumulus Synergy crée Accumulus Technologies pour développer sa plateforme réglementaire éprouvée et accélérer l’accès mondial aux thérapies

BURLINGAME, Californie, 07 août 2025 (GLOBE NEWSWIRE) -- Dans une démarche audacieuse visant à accélérer l’innovation réglementaire et à répondre à la demande mondiale croissante, Accumulus Synergy, une association professionnelle à but non lucratif, a …

アキュミュラスシナジー (Accumulus Synergy)、実績ある規制プラットフォームを拡大し、治療への世界的なアクセスを加速させるため、アキュミュラステクノロジーズ (Accumulus Technologies)…

アキュミュラスシナジー (Accumulus Synergy)、実績ある規制プラットフォームを拡大し、治療への世界的なアクセスを加速させるため、アキュミュラステクノロジーズ (Accumulus Technologies)…

カリフォルニア州バーリンゲーム発, Aug. 07, 2025 (GLOBE NEWSWIRE) -- 規制のイノベーションを迅速化し、拡大する世界的な需要に対応するための大胆な施策として、非営利の業界団体であるアキュミュラスシナジーは本日、アキュミュラスプラットフォーム (「プラットフォーム」) の拡大と進化を目的に設立された新たな商業技術企業、アキュミュラステクノロジーズの創設を発表した。同プラットフォームは、アキュミュラスシナジー内でインキュベートされ、2024 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions